Eighty million U.S. adults and children are currently enrolled in the nearly-free health care coverage offered to the poorest ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.